Zargis' Cardioscan Receives Televised News Coverage
April 18 2007 - 9:00AM
PR Newswire (US)
Segment Produced by Nonprofit Science and Engineering News Service
Affiliated with The American Institute of Physics and The National
Science Foundation PRINCETON, N.J., April 18 /PRNewswire/ -- Zargis
Medical Corp., a spin-off from Siemens Corporate Research (NYSE:SI)
and a majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE),
today announced that a 90-second news segment on its Cardioscan(R)
device recently aired on a number of local television stations
around the U.S. The news segment, entitled "Listen to Your Heart",
was produced by Discoveries and Breakthroughs Inside Science
(DBIS), a nonprofit syndicated news service operated by The
American Institute of Physics in partnership with a coalition of
scientific and engineering societies including The National Science
Foundation. DBIS' goal is to alert the public to the latest
"science and engineering news that matters" and promote an
awareness of the role that technical professionals play in society
and in people's daily lives. A total of 62 U.S. stations subscribe
to DBIS' monthly newsfeed, resulting in a potential audience reach
of more than 70 million. The Cardioscan news video can be viewed
online at
http://www.discoveriesandbreakthroughs.org/dbis/stories/2007/17024.html.
About Zargis Medical Corp. Zargis Medical Corp. develops advanced
diagnostic decision support products and services for primary care
physicians, pediatricians, cardiologists and other healthcare
professionals. Zargis was formed in 2001 when Siemens Corporate
Research, a division of Siemens AG (NYSE:SI), and Speedus Corp.
co-invested to develop and market an advanced acoustic technology
designed to detect heart abnormalities identified through analysis
of heart sounds. About Cardioscan Zargis has developed Cardioscan,
the first and only computer-assisted medical device designed to
support physicians in analyzing heart sounds for the identification
of suspected systolic and diastolic murmurs. Cardioscan is a
non-invasive device that is easy to use, portable, and takes just
minutes to perform. The device implements voice-guided protocol and
a graphical user interface while maintaining an efficient physician
workflow. Cardioscan provides a summary of findings in terms that
are readily understood by physicians and offers an additional range
of quantitative auscultatory information that cannot be obtained
through listening alone. As a result, Cardioscan enhances
auscultation-a procedure that has been universally employed through
a stethoscope for nearly two-hundred years. For additional
information about Zargis or Speedus Corp., contact Peter Hodge at
888.773.3669 (ext. 23) or or visit the following Web sites:
http://www.zargis.com/ and http://www.speedus.com/. Statements
contained herein that are not historical facts, including but not
limited to statements about the Company's product, corporate
identity and focus, may be forward-looking statements that are
subject to a variety of risks and uncertainties. There are a number
of important factors that could cause actual results to differ
materially from those expressed in any forward- looking statements
made by the Company, including, but not limited to, the continuing
development of the Company's sales, marketing and support efforts.
DATASOURCE: Zargis Medical Corp. CONTACT: Peter Hodge of Zargis
Medical Corp., +1-888-773-3669, ext. 23, or Web site:
http://www.zargis.com/ http://www.speedus.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024